|

Realgar-Indigo Naturalis Formulation Clinical Trials

1 actively recruiting trial

Also known as: Oral Arsenic

Pipeline

Phase 2: 1

Top Sponsors

  • Instituto do Cancer do Estado de São Paulo1

Indications

  • Acute Promyelocytic Leukemia (APL)1
  • Cancer1

Other1 trial

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.